explore -WSS

explore

author：knowledge 2025-09-02 22:22:14 - browse：685

Anna Yeo/STAT

Recently approved gene therapies offer patients one-time, potentially curative treatments for genetic diseases such as sickle cell anemia and beta thalassemia. But “one-time” miracle solutions can often be multi-month affairs, require millions of dollars, and cause painful side effects. What if that doesn’t have to be the case?

In utero gene editing, or prenatal somatic cell genome editing, envisions treating a fetus diagnosed with a genetic disease before birth, thereby preventing that entire protocol and the onset of symptoms in the first place. It would also challenge the need for the ethically fraught enterprise of embryo editing, as the treatment would only make edits in the DNA of the individual fetus — edits which would not be passed on in a heritable way.

Watch this video to learn more about in utero gene editing, how it works, and why scientists believe it might be an advantageous approach to treating certain genetic diseases.

Previous article： Hollywood unions extend contract negotiations for actors
Next article： RaDonda Vaught case: a double standard for nurses, physicians

WSS

Anavex keeps shifting the goalposts in its clinical trials

Meta looks to target Twitter with a rival app called Threads

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

Meta looks to target Twitter with a rival app called Threads

Police still searching for prisoner who escaped from NYC hospital

Man killed during FBI raid in connection with threats against Biden, other officials

knowledge

explore

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

Did the public have the right to know Arthur Ashe had AIDS?

Heart attack and stroke risk calculators need revising

Doctor appointment wait times are getting worse

George Santos makes 1st court appearance after pleading not guilty to 13 counts

For Cytokinetics, FDA rejection of heart drug would help, not hinder

Medical leaders decry Supreme Court decision on affirmative action

How to use technology to prevent future drug shortages

FDA approval of Sarepta Duchenne genetic therapy gives me hope

PhRMA sues HHS over Medicare drug price negotiation

hotspot

American woman, child freed after being kidnapped in Haiti last month

PhRMA sues HHS over Medicare drug price negotiation

Can food be medicine? And other questions about a new push

Community addresses injustice for Long Island mothers

What to know about Virgin Galactic's 1st mission taking paying customers to space

Wegovy trial has doctors encouraged over new possibilities

focus

focus

explore

focus